Torben Lykke Sørensen

Torben Lykke Sørensen

Clinical Professor, Senior Research Consultant

Member of:

  • Ophthalmology

ORCID: 0000-0002-6790-0199

Publication year:
All
71 - 80 out of 173Page size: 10
Sort by: Title
  1. Published

    Identification of foreign bodies on the ocular surface after uneventful intravitreal injections.

    Jørgensen, J. S., Kemp, H. & Sørensen, Torben Lykke, 2012, In: Acta Ophthalmologica. April , 4

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Imbalances in tissue inhibitors of metalloproteinases differentiate choroidal neovascularization from geographic atrophy

    Krogh Nielsen, M., Subhi, Y., Molbech, C. R., Nilsson, L. L., Nissen, Mogens Holst & Sørensen, Torben Lykke, 2019, In: Acta Ophthalmologica. 97, 1, p. 84-90

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Impact of COVID-19 restrictions on the treatment of neovascular age-related macular degeneration

    Bagi Nordsten, C., Rasmussen, B. K., Li, Xiaoqiang, Thomsen, Alexander Kai & Sørensen, Torben Lykke, 2024, In: Acta Ophthalmologica. 102, 3, p. e404-e405 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  4. Published

    In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels

    Subhi, Y., Singh, A., Falk, M. K. & Sørensen, Torben Lykke, 2014, In: Clinical ophthalmology (Auckland, N.Z.). 2014, 8, p. 15-21 7 p.

    Research output: Contribution to journal › Journal article › Research

  5. Published

    Increased CD40 ligand in patients with acute anterior uveitis

    Øgard, C., Sørensen, Torben Lykke & Krogh, E., Jun 2005, In: Acta Ophthalmologica. 83, 3, p. 370-3 4 p.

    Research output: Contribution to journal › Journal article › Research

  6. Published

    Increased Expression of CD200 on Circulating CD11b+ Monocytes in Patients with Neovascular Age-related Macular Degeneration

    Singh, A., Falk, M. K., Hviid, Thomas Vauvert F. & Sørensen, Torben Lykke, 12 Feb 2013, In: Ophthalmology, The American Academy of Ophthalmology.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Interleukin-8 Promoter Polymorphism -251 A/T and Treatment Response in Neovascular Age-related Macular Degeneration

    Thomsen, Alexander Kai, Krogh Nielsen, M., Liisborg, C. & Sørensen, Torben Lykke, 2024, In: Clinical ophthalmology (Auckland, N.Z.). 18, p. 537-543 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting

    Brynskov, T., Laugesen, C. S. & Sørensen, Torben Lykke, 31 Dec 2012, In: Acta Ophthalmologica.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes

    Laugesen, C. S., Ostri, C., Brynskov, T., Lund-Andersen, H., Larsen, Michael, Vorum, H. & Sørensen, Torben Lykke, Feb 2017, In: Acta Ophthalmologica. 95, 1, p. 28–32

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Intravitreal ranibizumab for retinal vein occlusion through 1 year use in clinical practice.

    Brynskov, T., Kemp, H. & Sørensen, Torben Lykke, Aug 2014, In: Retina. 34, 8, p. 1637–1643 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...4 5 6 7 8 9 10 11 ...18 Next

ID: 20664635